TC Biopharm (TCBP) Competitors $0.63 +0.00 (+0.32%) (As of 02:35 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrends TCBP vs. TFFP, ASLN, ZVSA, ADXS, QLGN, NMTR, EVFM, PTEIQ, PXMD, and CYCCShould you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include TFF Pharmaceuticals (TFFP), ASLAN Pharmaceuticals (ASLN), ZyVersa Therapeutics (ZVSA), Ayala Pharmaceuticals (ADXS), Qualigen Therapeutics (QLGN), 9 Meters Biopharma (NMTR), Evofem Biosciences (EVFM), PolarityTE (PTEIQ), PaxMedica (PXMD), and Cyclacel Pharmaceuticals (CYCC). These companies are all part of the "pharmaceutical products" industry. TC Biopharm vs. TFF Pharmaceuticals ASLAN Pharmaceuticals ZyVersa Therapeutics Ayala Pharmaceuticals Qualigen Therapeutics 9 Meters Biopharma Evofem Biosciences PolarityTE PaxMedica Cyclacel Pharmaceuticals TFF Pharmaceuticals (NASDAQ:TFFP) and TC Biopharm (NASDAQ:TCBP) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends. Is TFFP or TCBP more profitable? TC Biopharm has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,612.73%. TC Biopharm's return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TFF Pharmaceuticals-1,612.73% -225.15% -170.07% TC Biopharm N/A N/A N/A Which has more volatility and risk, TFFP or TCBP? TFF Pharmaceuticals has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, TC Biopharm has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Do institutionals and insiders hold more shares of TFFP or TCBP? 15.3% of TFF Pharmaceuticals shares are owned by institutional investors. Comparatively, 16.3% of TC Biopharm shares are owned by institutional investors. 4.5% of TFF Pharmaceuticals shares are owned by insiders. Comparatively, 15.4% of TC Biopharm shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to TFFP or TCBP? In the previous week, TFF Pharmaceuticals had 5 more articles in the media than TC Biopharm. MarketBeat recorded 5 mentions for TFF Pharmaceuticals and 0 mentions for TC Biopharm. TC Biopharm's average media sentiment score of 0.00 beat TFF Pharmaceuticals' score of -0.05 indicating that TC Biopharm is being referred to more favorably in the news media. Company Overall Sentiment TFF Pharmaceuticals Neutral TC Biopharm Neutral Do analysts recommend TFFP or TCBP? TFF Pharmaceuticals presently has a consensus target price of $44.00, suggesting a potential upside of 11,683.61%. Given TFF Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe TFF Pharmaceuticals is more favorable than TC Biopharm.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TFF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00TC Biopharm 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation & earnings, TFFP or TCBP? TC Biopharm has higher revenue and earnings than TFF Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTFF Pharmaceuticals$730K1.77-$21.24M-$7.88-0.05TC Biopharm$4.76M0.07-$7.35MN/AN/A Does the MarketBeat Community believe in TFFP or TCBP? TFF Pharmaceuticals received 66 more outperform votes than TC Biopharm when rated by MarketBeat users. Likewise, 67.68% of users gave TFF Pharmaceuticals an outperform vote while only 50.00% of users gave TC Biopharm an outperform vote. CompanyUnderperformOutperformTFF PharmaceuticalsOutperform Votes6767.68% Underperform Votes3232.32% TC BiopharmOutperform Votes150.00% Underperform Votes150.00% SummaryTFF Pharmaceuticals and TC Biopharm tied by winning 8 of the 16 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCBP vs. The Competition Export to ExcelMetricTC BiopharmBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$310,000.00$2.95B$5.06B$8.89BDividend YieldN/A1.90%4.97%4.06%P/E RatioN/A17.8689.0213.30Price / Sales0.07222.321,207.2881.01Price / CashN/A160.0839.1736.03Price / Book0.024.906.085.74Net Income-$7.35M-$41.63M$119.07M$225.93M7 Day Performance-1.72%-4.73%-1.84%-1.32%1 Month Performance-72.25%-6.53%-3.65%0.60%1 Year Performance-99.37%25.63%31.62%26.23% TC Biopharm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCBPTC Biopharm0.1442 of 5 stars$0.64+1.0%N/A-99.4%$337,000.00$4.76M0.0041Gap DownTFFPTFF Pharmaceuticals1.6867 of 5 stars$0.37+0.5%$44.00+11,655.3%-94.5%$1.30M$730,000.000.0019Gap UpHigh Trading VolumeASLNASLAN Pharmaceuticals1.1723 of 5 stars$0.60flat$76.00+12,566.7%N/A$1.23M$12M-0.0330ZVSAZyVersa Therapeutics2.3628 of 5 stars$1.15flat$120.00+10,334.8%-95.9%$1.18MN/A0.002ADXSAyala PharmaceuticalsN/A$0.03-74.8%N/A-96.7%$1.15M$10,000.000.0020Analyst ForecastNews CoverageGap DownQLGNQualigen TherapeuticsN/A$4.41+14.0%N/A-89.1%$1.10M$4.98M0.0050News CoverageGap UpNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220EVFMEvofem Biosciences0.8097 of 5 stars$0.01flatN/A-85.3%$1.03M$18.22M-0.02120Gap UpPTEIQPolarityTEN/A$0.13flatN/A+50.1%$923,000.00$810,000.00-0.0460Gap DownPXMDPaxMedicaN/A$0.07-33.0%$3.00+4,173.5%-89.3%$794,000.00N/A0.002Gap DownCYCCCyclacel Pharmaceuticals2.1409 of 5 stars$0.35-5.7%$11.00+3,042.9%-91.7%$752,000.00$420,000.000.0014Gap Down Related Companies and Tools Related Companies TFF Pharmaceuticals Alternatives ASLAN Pharmaceuticals Alternatives ZyVersa Therapeutics Alternatives Ayala Pharmaceuticals Alternatives Qualigen Therapeutics Alternatives 9 Meters Biopharma Alternatives Evofem Biosciences Alternatives PolarityTE Alternatives PaxMedica Alternatives Cyclacel Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCBP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TCBP Stock Alerts